School of Optometry 眼科視光學院
Home About Us What's New Subscribe eNewsletter Contact Us My School 繁體 简体 Text Only Print
About us
Message from Head of School
Vision & Mission
Our People
Academic Staff
Affiliate Faculty Members
Honorary & Adjunct Professor
Visiting Staff & Academic Visitors
Optometry Clinic Staff
Research Staff
Research Students
Our Research
About us > Our People > Research Students > Ms Li PAN
Our People
Mr. Chunghim SO | Mr. Dong LIANG | Mr. Milan RAI | Ms. Jing ZHANG | Ms. Shuwen JIA | Ms. Wing Yan LAU | Ms. Yingkun CUI | Ms Jingfang Jennifer BIAN | Mr Shashi Kant CHAUDHARY | Ms Meng CHENG | Mr Ka Wai Jimmy CHEUNG | Ms Hang I Christie LAM | Ms Hoi Lam LI | Ms Sonal Aswin VYAS | Mr Kin Ken WAN | Ms Biyue GUO | Ms Li PAN | Ms Qi TAN | Mr Mezbah UDDIN | Ms Rong LI | Ms. Yuanyuan LIANG | Ms Anqi LYU | Mr Ying Hon SZE | Ms Qin WANG | Ms Hanyu ZHANG | Ms Wei YANG | Ms Mei ZHAO | Ms Yajing YANG | Ms Fangyu XU | Mr Sung Hei Jimmy TSE | Ms. Seen Hang CHAN | Mr. CHAN Kin Ho | Ms. AYERAKWAH Patience Ansomah | Mr. SO Ching | Mr. CATRAL Kirk Patrick Carreon | Mr. LIU Zhengji | Mr. LU Daqian | Ms. QIU Chunting | Mr. YANG Xiayin


PhD Student

ORCiD 0000-0002-4839-7057

Title of project:
Traditional Chinese Medicines and Neuroprotection

The project aims to determine whether these TCMs can potentially be used as anti-glaucoma agents, and we shall investigate the effects of these TCMs on 1) IOP; and 2) neuroprotective effects; 3) mechanism of neuroprotection. The results of this project will enable us to understand the functional importance of baicalein as anti-glaucoma drugs. We hope that TCMs with fewer side effects can be developed for clinical use. 

Glaucoma is a progressive optic neuropathy characterized by a specific pattern of optic nerve head and visual field damage. Because of the absence of noticeable symptoms, glaucoma often leads to substantial visual loss before diagnosis. Until now, glaucoma remains incurable although its progression can be retarded by lowering the IOP by anti-glaucoma drugs. Neuroprotection has been proposed to facilitate in delaying the disease progression, but has not yet been successfully developed as an alternative treatment option. Because of the issues regarding drug resistance and patient compliance, novel agents with more potent and long-lasting actions are required. Baicalein (5,6,7-trihydroxyflavone) has a broad spectrum of bioactivity and has been shown that baicalein can be used in the treatment of neuropathies and cognitive impairment.